The day-to-day practice of MMR and MSI assessment in colorectal adenocarcinoma: what we know and what we still need to explore

P Parente, F Grillo, A Vanoli, MC Macciomei… - Dig. Dis, 2023 - karger.com
Abstract Background. The DNA Mismatch repair (MMR) system is a highly preserved protein
complex recognizing short insertions, short deletions and single base mismatches during …

Diagnostics and treatment of ovarian cancer in the era of precision medicine-opportunities and challenges

PA Bukłaho, J Kiśluk, J Nikliński - Frontiers in Oncology, 2023 - frontiersin.org
Due to predictions of increasing incidences and deaths from ovarian cancer, this neoplasm
is a challenge for modern health care. The advent of NGS technology has made it possible …

A comparative analysis of NOX4 protein expression in malignant and non-malignant thyroid tumors

S Fenniche, M Oukabli, Y Oubaddou, H Chahdi… - Current Issues in …, 2023 - mdpi.com
The comparative analysis of the expression of the reactive oxygen species-generating
NADPH oxidase NOX4 from TCGA data shows that the NOX4 transcript is upregulated in …

BRCA1 promoter hypermethylation in Malignant breast tumors and in the histologically normal adjacent tissues to the tumors: exploring its potential as a biomarker …

Y Oubaddou, M Oukabli, S Fenniche, A Elktaibi… - Genes, 2023 - mdpi.com
The hypermethylation status of the promoter region of the breast cancer 1 (BRCA1), a well-
known tumor suppressor gene, has been extensively investigated in the last two decades as …

Impact of formalin fixation on mismatch repair protein evaluation by immunohistochemistry

F Grillo, M Ali, M Paudice, S Pigozzi, G Anselmi… - Virchows Archiv, 2023 - Springer
Mismatch repair/microsatellite instability (MMR/MSI) status in colorectal cancer (CRC) has
become fundamental as a diagnostic, prognostic, and predictive factor. MMR …

Circulating tumor DNA analysis on metastatic prostate cancer with disease progression

S Bang, D Won, S Shin, KS Cho, JW Park, J Lee… - Cancers, 2023 - mdpi.com
Simple Summary In our study, we found genetic mutations in the DNA of cancer cells
obtained from the blood of many patients with metastatic prostate cancer. These changes …

Recent advances in molecular profiling of bone and soft tissue tumors

D Baumhoer, J Hench, F Amary - Skeletal Radiology, 2024 - Springer
The molecular characterization of soft tissue and bone tumors is a rapidly evolving field that
has changed the perspective of how these tumors are diagnosed today. Morphology and …

Could the tumor-associated microbiota be the new multi-faceted player in the tumor microenvironment?

AG Goubet - Frontiers in Oncology, 2023 - frontiersin.org
Microorganisms have been identified in tumor specimens for over a century. It is only in
recent years that tumor-associated microbiota has become a rapidly expanding field …

Molecular targets and strategies in the development of nucleic acid cancer vaccines: from shared to personalized antigens

WY Chi, Y Hu, HC Huang, HH Kuo, SH Lin… - Journal of Biomedical …, 2024 - Springer
Recent breakthroughs in cancer immunotherapies have emphasized the importance of
harnessing the immune system for treating cancer. Vaccines, which have traditionally been …

Choosing the Best Tissue and Technique to Detect Mosaicism in Fibrous Dysplasia/McCune–Albright Syndrome (FD/MAS)

Y Vado, A Manero-Azua, A Pereda… - Genes, 2024 - mdpi.com
GNAS-activating somatic mutations give rise to Fibrous Dysplasia/McCune–Albright
syndrome (FD/MAS). The low specificity of extra-skeletal signs of MAS and the mosaic status …